Related references
Note: Only part of the references are listed.The balance between lung regulatory T cells and Th17 cells is a risk indicator for the acute exacerbation of interstitial lung disease after surgery: a case-control study
Mariko Fukui et al.
BMC PULMONARY MEDICINE (2023)
Nintedanib in Idiopathic Pulmonary Fibrosis: Tolerability and Safety in a Real Life Experience in a Single Centre in Patients also Treated with Oral Anticoagulant Therapy
Barbara Ruaro et al.
PHARMACEUTICALS (2023)
Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
Ganesh Raghu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2022)
Clinical features of acute exacerbation in rheumatoid arthritis-associated interstitial lung disease: Comparison with idiopathic pulmonary fibrosis
Junji Otsuka et al.
RESPIRATORY MEDICINE (2022)
Editorial: Pulmonary fibrosis: One manifestation, various diseases
Barbara Ruaro et al.
FRONTIERS IN PHARMACOLOGY (2022)
National data on prevalence of idiopathic pulmonary fibrosis and antifibrotic drug use in Finnish specialised care
Johanna Salonen et al.
BMJ OPEN RESPIRATORY RESEARCH (2022)
Acute exacerbation of rheumatoid arthritis-associated interstitial lung disease: mortality and its prediction model
Hironao Hozumi et al.
RESPIRATORY RESEARCH (2022)
The Effect of Nintedanib on T-Cell Activation, Subsets and Functions
Kenia Ubieta et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2021)
Initial therapeutic dose of corticosteroid for an acute exacerbation of IPF is associated with subsequent early recurrence of another exacerbation
Ryo Yamazaki et al.
SCIENTIFIC REPORTS (2021)
Antifibrotic therapies reduce mortality and hospitalization among Medicare beneficiaries with idiopathic pulmonary fibrosis
Joshua Mooney et al.
JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY (2021)
A systematic review of the incidence, risk factors and prognosis of acute exacerbation of systemic autoimmune disease-associated interstitial lung disease
Hiroyuki Kamiya et al.
BMC PULMONARY MEDICINE (2021)
Interstitial Lung Disease at High Resolution CT after SARS-CoV-2-Related Acute Respiratory Distress Syndrome According to Pulmonary Segmental Anatomy
Elisa Baratella et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Acute exacerbation of fibrotic hypersensitivity pneumonitis: incidence and outcomes
Jieun Kang et al.
RESPIRATORY RESEARCH (2021)
Acute exacerbations of fibrotic interstitial lung diseases
Atsushi Suzuki et al.
RESPIROLOGY (2020)
Pirfenidone: Molecular Mechanisms and Potential Clinical Applications in Lung Disease
Saleela M. Ruwanpura et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2020)
Corticosteroid use is not associated with improved outcomes in acute exacerbation of IPF
Erica Farrand et al.
RESPIROLOGY (2020)
Spectrum of Fibrotic Lung Diseases
Marlies Wijsenbeek et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Prognosis and causes of death of patients with acute exacerbation of fibrosing interstitial lung diseases
Johanna Salonen et al.
BMJ OPEN RESPIRATORY RESEARCH (2020)
Hospitalisation patterns of patients with interstitial lung disease in the light of comorbidities and medical treatment - a German claims data analysis
Julia Waelscher et al.
RESPIRATORY RESEARCH (2020)
Characteristics and outcomes of patients hospitalized with interstitial lung diseases in Spain, 2014 to 2015
Fernando Pedraza-Serrano et al.
MEDICINE (2019)
Acute exacerbation of chronic fibrosing interstitial pneumonia in patients receiving antifibrotic agents: incidence and risk factors from real-world experience
Kodai Kawamura et al.
BMC PULMONARY MEDICINE (2019)
The utility of the Japanese Association for Acute Medicine DIC scoring system for predicting survival in acute exacerbation of fibrosing idiopathic interstitial pneumonia
Ryo Yamazaki et al.
PLOS ONE (2019)
Acute exacerbations of fibrosing interstitial lung disease associated with connective tissue diseases: a population-based study
Mengshu Cao et al.
BMC PULMONARY MEDICINE (2019)
Prognostic differences among patients with idiopathic interstitial pneumonias with acute exacerbation of varying pathogenesis: a retrospective study
Motoyasu Kato et al.
RESPIRATORY RESEARCH (2019)
Diagnosis of Idiopathic Pulmonary Fibrosis An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
Ganesh Raghu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
Differences in clinical features of acute exacerbation between connective tissue disease-associated interstitial pneumonia and idiopathic pulmonary fibrosis
Noriyuki Enomoto et al.
CHRONIC RESPIRATORY DISEASE (2018)
Acute exacerbations of progressive-fibrosing interstitial lung diseases
Martin Kolb et al.
EUROPEAN RESPIRATORY REVIEW (2018)
Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases
Vincent Cottin et al.
EUROPEAN RESPIRATORY REVIEW (2018)
Azithromycin for idiopathic acute exacerbation of idiopathic pulmonary fibrosis: a retrospective single-center study
Kodai Kawamura et al.
BMC PULMONARY MEDICINE (2017)
Retrospective observational study of trends in hospital admissions for idiopathic pulmonary fibrosis in Spain (2004-2013) using administrative data
Fernando Pedraza-Serrano et al.
BMJ OPEN (2017)
Burden of Idiopathic Pulmonary Fibrosis Progression: A 5-Year Longitudinal Follow-Up Study
Vincent Cottin et al.
PLOS ONE (2017)
Acute Exacerbation and Decline in Forced Vital Capacity Are Associated with Increased Mortality in Idiopathic Pulmonary Fibrosis
Miya O. Paterniti et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2017)
Acute Exacerbation of Idiopathic Pulmonary Fibrosis An International Working Group Report
Harold R. Collard et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2016)
Patients With Fibrotic Interstitial Lung Disease Hospitalized for Acute Respiratory Worsening A Large Cohort Analysis
Teng Moua et al.
CHEST (2016)
Nintedanib in patients with idiopathic pulmonary fibrosis: Combined evidence from the TOMORROW and INPULSIS® trials
Luca Richeldi et al.
RESPIRATORY MEDICINE (2016)
Heterogeneity of incidence and outcome of acute exacerbation in idiopathic interstitial pneumonia
Toru Arai et al.
RESPIROLOGY (2016)
End-of-life care of patients with idiopathic pulmonary fibrosis
Kaisa Rajala et al.
BMC PALLIATIVE CARE (2016)
Patterns and Economic Burden of Hospitalizations and Exacerbations Among Patients Diagnosed with Idiopathic Pulmonary Fibrosis
Yanni F. Yu et al.
Journal of Managed Care & Specialty Pharmacy (2016)
Risk factors for an acute exacerbation of idiopathic pulmonary fibrosis
Tomoyuki Kakugawa et al.
RESPIRATORY RESEARCH (2016)
Macrophage Activation in Acute Exacerbation of Idiopathic Pulmonary Fibrosis
Jonas Christian Schupp et al.
PLOS ONE (2015)
Acute exacerbation of idiopathic pulmonary fibrosis associated with air pollution exposure
Kerri A. Johannson et al.
EUROPEAN RESPIRATORY JOURNAL (2014)
A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
Talmadge E. King et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias
William D. Travis et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Clinical Features and Outcome of Acute Exacerbation of Interstitial Pneumonia: Collagen Vascular Diseases-Related versus Idiopathic
Ryo Tachikawa et al.
RESPIRATION (2012)
Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome
J. W. Song et al.
EUROPEAN RESPIRATORY JOURNAL (2011)
A detailed evaluation of acute respiratory decline in patients with fibrotic lung disease: Aetiology and outcomes
Tristan J. Huie et al.
RESPIROLOGY (2010)
Share Paper
